Authors
Alex Y Doets, Christine Verboon, Bianca Van Den Berg, Thomas Harbo, David R Cornblath, Hugh J Willison, Zhahirul Islam, Shahram Attarian, Fabio A Barroso, Kathleen Bateman, Luana Benedetti, Peter Van Den Bergh, Carlos Casasnovas, Guido Cavaletti, Govindsinh Chavada, Kristl G Claeys, Efthimios Dardiotis, Amy Davidson, Pieter A Van Doorn, Tom E Feasby, Giuliana Galassi, Kenneth C Gorson, Hans-Peter Hartung, Sung-Tsang Hsieh, Richard AC Hughes, Isabel Illa, Badrul Islam, Susumu Kusunoki, Satoshi Kuwabara, Helmar C Lehmann, James AL Miller, Quazi Deen Mohammad, Soledad Monges, Eduardo Nobile Orazio, Julio Pardo, Yann Pereon, Simon Rinaldi, Luis Querol, Stephen W Reddel, Ricardo C Reisin, Nortina Shahrizaila, Soren H Sindrup, Waheed Waqar, Bart C Jacobs
Publication date
2018/10/1
Journal
Brain
Volume
141
Issue
10
Pages
2866-2877
Publisher
Oxford University Press
Description
Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation, electrophysiological subtype and outcome. Previous single country reports indicate that Guillain-Barré syndrome may differ among regions, but no systematic comparative studies have been conducted. Comparative studies are required to identify factors determining disease susceptibility, variation and prognosis, and to improve diagnostic criteria. The International Guillain-Barré Syndrome Outcome Study is a prospective, observational cohort study including all patients within the diagnostic spectrum, aiming to describe the heterogeneity of Guillain-Barré syndrome worldwide. The current study was based on the first 1000 inclusions with a follow-up of at least 1 year and confirmed the variation in clinical presentation, course and outcome between patients. The full clinical spectrum of Guillain-Barré syndrome was observed …
Scholar articles
AY Doets, C Verboon, B Van Den Berg, T Harbo… - Brain, 2018